Alleviant Medical secures $90m to launch pivotal aortic stent trial
Texas medical device firm Alleviant Medical has secured $90m to fund a second pivotal trial of the company’s heart system…
News
JP Morgan 2025: Moderna stock suffers after CEO reveals conservative 2025 guidance
Hengrui and Kailera report best-in-class data from Phase II GLP-1/GIP trial
BlueRock accelerates Parkinson’s disease therapy to Phase III
JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Pfizer pitches pipeline priorities in oncology and obesity at JP Morgan 2025
Broader population could benefit from Novartis spinal muscular atrophy treatment
Onera’s validation trial of home polysomnography sleep device succeeds
